Across STEP-1, STEP-2, STEP-3, and STEP-4, vomiting incidence in semaglutide arms ranged from 16% to 29%, consistently exceeding placebo rates of 4% to 9% ([4],[8],[12],[13])
This effect on gastric emptying tends to diminish somewhat over time as the body adapts
Theres one more wrinkle that makes Canada particularly interesting from a manufacturing standpoint: the dominant dosage format here isnt a standard pre-filled pen its a DDC (Drug Device Combination) cartridge that loads into a reusable pen device
[cited 2024 Jan 31]
Nausea typically occurs during the first 4-8 weeks of treatment or following dose increases, with many patients experiencing gradual improvement as their body adjusts to the medication
its about helping you feel better, live healthier, and regain confidence in your body